These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2997097

  • 1. Phase II study of vindesine in patients with non-small cell lung cancer.
    Fujita J, Saijo N, Eguchi K, Shinkai T, Tominaga K, Sasaki Y, Futami H, Sakurai M, Ishihara J, Takahashi H.
    Jpn J Cancer Res; 1985 Sep; 76(9):902-5. PubMed ID: 2997097
    [Abstract] [Full Text] [Related]

  • 2. [A phase II study of vindesine for pretreated non-small cell lung cancer].
    Shimizu E, Nakamura Y, Yamasaki K, Kimura K, Inoue I, Nakahira S, Kawahito K, Tani K, Sone S, Yamashita T.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
    [Abstract] [Full Text] [Related]

  • 3. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M, Saijo N, Shimizu E, Eguchi K, Shinkai T, Tominaga K, Shimabukuro Z.
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
    [Abstract] [Full Text] [Related]

  • 4. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE, Williams SD, Einhorn LH, Cobleigh MA.
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [Abstract] [Full Text] [Related]

  • 5. Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.
    Gralla RJ, Raphael BG, Golbey RB, Young CW.
    Cancer Treat Rep; 1979 Aug; 63(8):1343-6. PubMed ID: 225028
    [Abstract] [Full Text] [Related]

  • 6. [An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
    Haneda H, Koizumi M, Hayashi T.
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):227-31. PubMed ID: 10700892
    [Abstract] [Full Text] [Related]

  • 7. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K, Hørbov S, Dombernowsky P, Rørth M, Hansen HH.
    Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].
    Tominaga K, Saijo N, Eguchi K, Shinkai T, Shimizu E.
    Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Sep; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 14. [A phase II study of epirubicin in advanced lung cancer].
    Furuse K, Fukuoka M, Yamamoto M, Kawahara M, Tsuruta M, Kodama N, Arai R, Hayashi S, Kiyota M, Kubota K.
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2835-40. PubMed ID: 3019252
    [Abstract] [Full Text] [Related]

  • 15. [Cis-dichlorodiammine platinum (II) CDDP in the treatment of non-small cell lung cancer].
    Eguchi K, Shimizu E, Saijo N, Sasaki Y, Shinkai T, Tominaga K.
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1764-9. PubMed ID: 6541021
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ, Arnold E, Walter M, Sander U.
    Fortschr Med; 1984 Sep 06; 102(33):811-4. PubMed ID: 6090286
    [Abstract] [Full Text] [Related]

  • 17. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Sep 06; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 18. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ, Aisner J, Carney DN, Van Echo DA, Ostrow SS, Ihde DC, Wiernik PH.
    Am J Clin Oncol; 1982 Feb 06; 5(1):49-52. PubMed ID: 6282108
    [Abstract] [Full Text] [Related]

  • 19. [Phase II study of cis-dichlorodiammineplatinum (II) for non-small cell lung cancer].
    Fukuoka M, Furuse K, Takada M, Negoro S, Tamai S, Matsui K, Sakai N, Ryu S, Yoshinaga T, Kawahara M.
    Gan To Kagaku Ryoho; 1985 Mar 06; 12(3 Pt 1):471-8. PubMed ID: 2988455
    [Abstract] [Full Text] [Related]

  • 20. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ, Peterson BA, Kennedy BJ, Vosika GJ, Conroy JA.
    Am J Clin Oncol; 1982 Feb 06; 5(1):41-4. PubMed ID: 6282107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.